Shopping Cart
Remove All
Your shopping cart is currently empty
AZD0516 is a pioneering antibody-drug conjugate (ADC) targeting Six Transmembrane Epithelial Antigen of the Prostate 2 (STEAP2). It is composed of an anti-STEAP2 monoclonal antibody (mAb) linked via a cysteine-maleimide reactive, β-glucuronidase-cleavable linker to the topoisomerase 1 inhibitor Exatecan. AZD0516 is applicable for prostate cancer research.
| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 1 mg | Inquiry | Inquiry | Inquiry | |
| 5 mg | Inquiry | Inquiry | Inquiry |
| Description | AZD0516 is a pioneering antibody-drug conjugate (ADC) targeting Six Transmembrane Epithelial Antigen of the Prostate 2 (STEAP2). It is composed of an anti-STEAP2 monoclonal antibody (mAb) linked via a cysteine-maleimide reactive, β-glucuronidase-cleavable linker to the topoisomerase 1 inhibitor Exatecan. AZD0516 is applicable for prostate cancer research. |
| Reactivity | Human |
| Application | FACS Functional assay |
| Antibody Type | Monoclonal |
| Endotoxin | < 1.0 EU/mg |
| Target | STEAP2 |
| Storage | store at low temperature | -20°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.